Literature DB >> 24551440

Cord blood -fetoprotein as a predictive index for indirect hyperbilirubinemia in term neonates.

Yadollah Zahedpasha1, Mousa Ahmadpour-Kacho1, Jafar Khalafi1, Ali Bijani1.   

Abstract

BACKGROUND: Prediction of severe neonatal hyperbilirubinemia is very important for early treatment and prophylaxis of neurologic sequels. The aim of this study was to evaluate the predictive role of umbilical cord -fetoprotein (UCAFP) as a marker of an increased risk for neonatal hyperbilirubinemia in full term babies.
METHODS: Umbilical cord blood was collected from 400 term singleton full term well newborn babies who met our inclusion criteria and stored in -20°C. Those who developed jaundice and admitted for phototherapy (34 newborns: 22 males and 12 females), considered as case group and 31 non-jaundiced infants (13 males and 18 females) gestational age-weight-matched considered as the control group. The serum level of UCAFP was checked in these 65 newborns and was compared between these two groups.
RESULTS: Mean UCAFP in case group was 523.429±174.158 and in control group was 664.548±154.894 μg/L. In the non-jaundiced group, mean UCAFP values was higher than neonate with hyperbilirubinemia (664.548 vs. 523.429μg/L). The mean UCAFP in males was 519.023 μg/L and in females was 531.508 μg/L (p=0.066). Sixty (92.3%) babies delivered by cesarean section (CS) and 5 (7.7%) by normal vaginal delivery (p=0.566).
CONCLUSION: According to our study, there was no significant positive association between UCAFP and subsequent neonatal indirect hyperbilirubinemia or serum bilirubin level.

Entities:  

Keywords:  Alpha-fetoprotein; Hyperbilirubinemia; Term neonate

Year:  2011        PMID: 24551440      PMCID: PMC3895831     

Source DB:  PubMed          Journal:  Caspian J Intern Med        ISSN: 2008-6164


  29 in total

1.  System-based approach to management of neonatal jaundice and prevention of kernicterus.

Authors:  Lois H Johnson; Vinod K Bhutani; Audrey K Brown
Journal:  J Pediatr       Date:  2002-04       Impact factor: 4.406

2.  Breastfeeding and jaundice.

Authors:  L M Gartner
Journal:  J Perinatol       Date:  2001-12       Impact factor: 2.521

3.  Serum alpha-fetoprotein in newborns

Authors: 
Journal:  Clin Chem       Date:  1998-12       Impact factor: 8.327

4.  Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.

Authors:  Adrian M Di Bisceglie; Richard K Sterling; Raymond T Chung; James E Everhart; Jules L Dienstag; Herbert L Bonkovsky; Elizabeth C Wright; Gregory T Everson; Karen L Lindsay; Anna S F Lok; William M Lee; Timothy R Morgan; Marc G Ghany; David R Gretch
Journal:  J Hepatol       Date:  2005-09       Impact factor: 25.083

5.  The effect of diet on feces and jaundice during the first 3 weeks of life.

Authors:  G R Gourley; B Kreamer; R Arend
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

6.  A controlled, randomized, double-blind trial of prophylaxis against jaundice among breastfed newborns.

Authors:  Glenn R Gourley; Zhanhai Li; Bill L Kreamer; Michael R Kosorok
Journal:  Pediatrics       Date:  2005-08       Impact factor: 7.124

7.  The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver.

Authors:  N Kawade; S Onishi
Journal:  Biochem J       Date:  1981-04-15       Impact factor: 3.857

8.  Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese.

Authors:  K Akaba; T Kimura; A Sasaki; S Tanabe; T Ikegami; M Hashimoto; H Umeda; H Yoshida; K Umetsu; H Chiba; I Yuasa; K Hayasaka
Journal:  Biochem Mol Biol Int       Date:  1998-09

9.  [Alpha fetoprotein and neonatal jaundice. Contribution to the study of a physiopathologic mechanism].

Authors:  C E Tourne; J P Brettes; G Guez; J Ritter; R Gandar
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  1977 Apr-May

10.  Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns.

Authors:  V K Bhutani; L Johnson; E M Sivieri
Journal:  Pediatrics       Date:  1999-01       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.